Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Venture Capital

Kbp Biosciences Raises $76m In Series A Financing And Appoints Brian P. Mcveigh As Chief Executive Officer

by posted 1year ago 334 views
KBP Biosciences Raises $76 Million in Series A Financing and Appoints Brian P. McVeigh as Chief Executive Officer– Established China Biotechnology Company with Deep R&D; Pipeline Opens Global Headquarters in the United States – – Proceeds will also advance clinical development of lead candidate, KBP-5074, through Phase 2b trials for cardiovascular disease – JINAN, China & PHILADELPHIA, January 5, 2018-- KBP Biosciences, a private clinical-stage biotechnology company dedicated to the research, development and commercialization of innovative medicines in areas of unmet medical need, today announced the closing of a $76 million Series A financing.